参考文献/References:
[1] Uchino M,Yamashita S,Uchino K,et al.Yamashita T et al:muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis[J].Clin Neurol Neurosurg,2013,115(5):603-606.
[2] Wegener S,Bremer J,Komminoth P,et al.Paraneoplastic necrotizing myopathy with a mild inflammatory component:a case report and review of the literature[J].Case Rep Oncol,2010,3(1):88-92.
[3] Acciavatti A,Avolio T,Rappuoli S,et al.Paraneoplastic necrotizing myopathy associated with adenocarcinoma of the lung-a rare entity with atypical onset:a case report[J].J Med Case Rep,2013,7:112.
[4] Zampieri S,Valente M,Adami N,et al.Kern H et al:polymyositis,dermatomyositis and malignancy:a further intriguing Link[J].Autoimmun Rev,2010,9(6):449-453.
[5] Targoff IN,Mamyrova G,Trieu EP,et al.O'hanlon TP,miller FW,rider LG,childhood myositis heterogeneity study G,international myositis collaborative study G:A novel autoantibody to a 155-kd protein is associated with dermatomyositis[J].Arthritis Rheum,2006,54(11):3682-3689.
[6] Fiorentino DF,Chung LS,Christopher-Stine L,et al.Most patients with Cancer-Associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1 gamma[J].Arthritis Rheum,2013,65(11):2954-2962.
[7] Trallero-Araguas E,Rodrigo-Pendas JA.Selva-O'callaghan a,Martinez-Gomez X,bosch X,Labrador-Horrillo M,Grau-Junyent JM,Vilardell-Tarres M:usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis:a systematic review and meta-analysis[J].Arthritis Rheum,2012,64(2):523-532.
[8] Hoshino K,Muro Y,Sugiura K,et al.Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis[J].Rheumatology,2010,49(9):1726-1733.
[9] 杨阚波,舒晓明,彭清林,等.血清抗转录中介因子1-γ抗体在多发性肌炎/皮肌炎合并肿瘤诊断中的价值[J].中华风湿病学杂志,2013,17(1):10-15.
[10] Kasuya A,Hamaguchi Y,Fujimoto M,et al.TIF1gamma-overexpressing,highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody[J].Acta Derm Venereol,2013,93(6):715-716.
[11] Pinal-Fernandez I,Casciola-Rosen LA,Corse AM,et al.The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis[J].Journal of Rheumatology,2015,42(8):1448-1454.
[12] Miller T,Al-Lozi MT,Lopate G,et al.Myopathy with antibodies to the signal recognition particle: clinical and pathological features[J].J Neurol Neurosurg Psychiatry,2002,73(4):420-428.
[13] Wantke F,Kneussl M,Hubner M,et al.(SRP)positive myositis in a patient with cryptogenic organizing pneumonia(COP)[J].Rheumatology International,2010,30(10):1361-1365.
[14] Hanisch F,Mueller T,Stoltenburg G,et al.Unusual manifestations in two cases of necrotizing myopathy associated with SRP-antibodies[J].Clin Neurol Neurosurg,2012,114(7):1104-1106.
[15] Kawabata T,Komaki H,Saito T,et al.Momomura M et al:A pediatric patient with myopathy associated with antibodies to a signal recognition particle[J].Brain Dev,2012,34(10):877-880.
[16] Apiwattanakul M,Milone M,Pittock SJ,et al.O'toole O,McKeon A,lennon VA:signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy[J].Muscle Nerve,2016,53(6):925-932.
[17] 李毅,付俊,孟令超,等.免疫性坏死性肌病临床特点分析[J].中国现代神经疾病杂志,2016,16(10):689-695.
[18] Hengstman G,Ter Laak HJ,Egberts WM,et al.Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy[J].Ann Rheum Dis,2006,65(12):1635-1638.
[19] Sampson JB,Smith SM,Smith AG,et al.Paraneoplastic myopathy: response to intravenous immunoglobulin[J].Neuromuscular Disorders,2007,17(5):404-408.
[20] Lee YJ,Kim HS,Ryu AJ,et al.Enhanced production of full-length immunoglobulin G via the signal recognition particle(SRP)-dependent pathway in Escherichia coli[J].J Biotechnol,2013,165(2):102-108.
[21] Suzuki S, Yonekawa T, Kuwana M, et al. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies[J]. Journal of Neuroimmunology, 2014, 274(1-2):202-208.
[22] Suzuki S, Nishikawa A, Kuwana M,et al. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet Journal of Rare Diseases,2015, 10:61.
[23] Rojana-Udomsart A,Mitrpant C,Bundell C,et al.Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy(ASANM)[J].J Neuroimmunol,2013,264(1/2):65-70.
[24] Stenzel W,Goebel HH,Aronica E.Review: immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features[J].Neuropathol Appl Neurobiol,2012,38(7):632-646.
[25] Christopher-Stine L,Casciola-Rosen LA,Hong GA,et al.A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an Immune-Mediated necrotizing myopathy[J].Arthritis Rheum,2010,62(9):2757-2766.
[26] Mammen AL,Chung T,Christopher-Stine L,et al.Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy[J].Arthritis Rheum,2011,63(3):713-721.
[27] Limaye V, Bundell C, Hollingsworth P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy[J]. Muscle & Nerve, 2015, 52(2):196-203.
[28] Allenbach Y, Kaeren J, Bouvier A, et al. GO 8-Cancer and necrotizing immune myopathy: High incidence in anti-HMGCR positive and seronegative patients but not in anti-SRP positive patients[J]. Neuromuscular Disorders,2015, 25:S245.
[29] Basharat P, Lahouti AH, Mammen AL,et al. Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase. In: Arthritis & rheumatology:. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA,2014: S554-S554.
[30] Allenbach Y,Drouot L,Rigolet A,et al.Laforet P et al:Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies:inconstant exposure to statin[J].Medicine,2014,93(3):150-157.
[31] Chung T,Christopher-Stine L,Paik JJ,et al.The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy[J].Muscle Nerve,2015,52(2):189-195.
[32] Watanabe Y,Suzuki S,Nishimura H,et al.Kawabata S et al:statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies:an observational study in Japan[J].Medicine,2015,94(4):e416.